I 118th CONGRESS 2d Session H. R. 7823 IN THE HOUSE OF REPRESENTATIVES March 26, 2024 Mrs. Miller of Illinois (for herself, Mr. Babin , Ms. Hageman , Mr. Rosendale , Mrs. Harshbarger , Mr. Banks , and Mr. Webster of Florida ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.